Unraveling the Gut Microbiota: Key Insights into its Role in Gastrointestinal and Cardiovascular Health

Seema Charitha Cheemala

Rajiv Gandhi Institute of Medical Sciences, Adilabad, Telangana, India.

Saif Syed

RCSI Royal College of Surgeons in Ireland, Dublin, Ireland.

Ruqiya Bibi

Allama Iqbal Medical College, Lahore, Pakistan.

Muawaz Bin Suhail

Allama Iqbal Medical College, Lahore, Pakistan.

Mayankkumar D Dhakecha

Government Medical College, Surat, India.

Muhammad Subhan *

Allama Iqbal Medical College, Lahore, Pakistan and Jinnah Hospital Lahore, Pakistan.

Muhammad Shoaib Mahmood

Akhtar Saeed Medical and Dental College, Lahore, Pakistan.

Ahsan Shabbir

Akhtar Saeed Medical and Dental College, Lahore, Pakistan.

Hamza Islam

Punjab Medical College, Faisalabad, Pakistan.

Rabia Islam

Punjab Medical College, Faisalabad, Pakistan.

*Author to whom correspondence should be addressed.


Abstract

The human gastrointestinal (GI) tract harbors a diverse and dynamic community of microorganisms known as the gut microbiome, which plays a fundamental role in maintaining gastrointestinal (GI) and cardiovascular health. It explores the intricate interplay between the gut microbiota, GI health, and cardiovascular diseases (CVDs). It discusses the essential roles of the gut microbiome in energy metabolism, nutrient absorption, immune regulation, and gut barrier integrity. Dysbiosis, characterized by an imbalance in gut microbiota composition, has been linked to various GI conditions, including inflammatory bowel diseases (IBD) and irritable bowel syndrome (IBS), as well as CVDs such as hypertension, atherosclerosis, and heart failure. Therapeutic strategies targeting the gut microbiome, including probiotics, prebiotics, fecal microbiota transplantation (FMT), and precision nutrition, offer promising avenues for managing GI and cardiovascular diseases. Recent research has brought attention to the significance of gut microbiota in CVDs, highlighting sex-specific variations, microbial metabolites' impact, and potential therapeutic interventions. Challenges in microbiome research, such as sample size limitations and methodological variability, are addressed, along with opportunities for innovation, including multi-omics integration and personalized medicine guided by microbiome data. By addressing these challenges and leveraging opportunities, gut microbiome research can revolutionize healthcare, ushering in a new era of personalized and microbiome-informed medicine. This comprehensive analysis offers valuable perspectives into the intricate relationship between gut microbiota, GI health, and cardiovascular diseases, paving the way for future research and clinical applications in this burgeoning field.

Keywords: Gut microbiota, cardiovascular Health, gastrointestinal diseases, bacteria


How to Cite

Cheemala , Seema Charitha, Saif Syed, Ruqiya Bibi, Muawaz Bin Suhail, Mayankkumar D Dhakecha, Muhammad Subhan, Muhammad Shoaib Mahmood, Ahsan Shabbir, Hamza Islam, and Rabia Islam. 2024. “Unraveling the Gut Microbiota: Key Insights into Its Role in Gastrointestinal and Cardiovascular Health”. Journal of Advances in Medicine and Medical Research 36 (7):34-47. https://doi.org/10.9734/jammr/2024/v36i75483.

Downloads

Download data is not yet available.

References

Sender R, Fuchs S, Milo R. Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans. Cell. 2016;164(3):337-340.

Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823-1836.

3.Sonnenburg JL, Sonnenburg ED. Vulnerability of the industrialized microbiota. Science. 2019 Oct 25; 366(6464):eaaw9255. doi:10.1126/science.aaw9255. PMID: 31649168.

Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121-141.

Boutagy NE, McMillan RP, Frisard MI, Hulver MW. Metabolic endotoxemia with obesity: Is it real and is it relevant? Biochimie. 2016 May;124:11-20. DOI:10.1016/j.biochi.2015.06.020. Epub 2015 Jun 29. PMID: 26133659; PMCID: PMC4695328.

Spencer CN, McQuade JL, Gopalakrishnan V, et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science. 2021 Dec 24;374(6575):1632-1640. DOI: 10.1126/science.aaz7015. Epub 2021 Dec 23. PMID: 34941392; PMCID: PMC8970537.

Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016;65(2):330-339.

Tan J, Taitz J, Nanan R, Grau G, Macia L. Dysbiotic Gut Microbiota-Derived Metabolites and Their Role in Non-Communicable Diseases. Int J Mol Sci. 2023 Oct 17;24(20):15256. DOI: 10.3390/ijms242015256. PMID: 37894934; PMCID: PMC10607102.

Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8(1):845.

Volodina DE, Gureev AP, Shaforostova EA, Gryaznova MV, Ignatyeva DA, Popov VN. Effect of l-carnitine and mildronate on the mitochondrial metabolism of heart and bacterial composition of the gut microbiome in ageing mice. Life Sci. 2022 Mar 15;293:120333. DOI:10.1016/j.lfs.2022.120333. Epub 2022 Jan 18. PMID: 35051422.

Tang WH, Hazen SL. The contributory role of gut microbiota in cardiovascular disease. J Clin Invest. 2014;124(10):4204-4211.

Ma J, Li H. The role of gut microbiota in atherosclerosis and hypertension. Front Pharmacol. 2018;9:1082.

Belli M, Barone L, Longo S, Prandi FR, Lecis D, Mollace R, Margonato D, Muscoli S, Sergi D, Federici M, et al. Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target? International Journal of Molecular Sciences. 2023;24(15):11971.

Available:https://doi.org/10.3390/ijms241511971

Emoto T, Yamashita T, Sasaki N, Hirota Y, Hayashi T, So A, et al. Analysis of gut microbiota in coronary artery disease patients: a possible link between gut microbiota and coronary artery disease. J Atheroscler Thromb. 2016;23(8):908-921.

Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016;165(1):111-124.

Koopen AM, Groen AK, Nieuwdorp M. Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk. Biochim Biophys Acta Mol Basis Dis. 2019;1865(7): 981-984.

Jonsson AL, Bäckhed F. Role of gut microbiota in atherosclerosis. Nat Rev Cardiol. 2017;14(2):79-87.

18.Clapp M, Aurora N, Herrera L, Bhatia M, Wilen E, Wakefield S. Gut microbiota's effect on mental health: The gut-brain axis. Clin Pract. 2017 Sep 15;7(4):987. DOI: 10.4081/cp.2017.987. PMID: 29071061; PMCID: PMC5641835.

Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018 Jun 13;361:k2179. DOI:10.1136/bmj.k2179.

PMID: 29899036; PMCID: PMC6000740.

Vandeputte D, Kathagen G, D'hoe K, Vieira-Silva S, Valles-Colomer M, Sabino J, Wang J, Tito RY, De Commer L, Darzi Y, Vermeire S, Falony G, Raes J. Quantitative microbiome profiling links gut community variation to microbial load. Nature. 2017 Nov 23;551(7681):507-511. DOI:10.1038/nature24460. Epub 2017 Nov 15.

PMID: 29143816.

Zhao T, Wang X, Fu L, Yang K. Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response. Cancer Drug Resist. 2022 May 12;5(2):436-450. DOI:10.20517/cdr.2021.144.

PMID: 35800370; PMCID: PMC9255244.

Wang L, Wang S, Zhang Q, He C, Fu C, Wei Q. The role of the gut microbiota in health and cardiovascular diseases. Mol Biomed. 2022 Oct 11;3(1):30.DOI: 10.1186/s43556-022-00091-2.

PMID: 36219347; PMCID: PMC9554112.

Garcia-Fernandez H, Arenas-de Larriva AP, Lopez-Moreno J, Gutierrez-Mariscal FM, Romero-Cabrera JL, Molina-Abril H, Torres-Peña JD, Rodriguez-Cano D, Malagon MM, Ordovas JM, Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Camargo A. Sex-specific differences in intestinal microbiota associated with cardiovascular diseases. Biol Sex Differ. 2024 Jan 19;15(1):7. DOI: 10.1186/s13293-024-00582-7. PMID: 38243297; PMCID: PMC10797902.

Khan M, Shah S, Shah W, Khan I, Ali H, Ali I, Ullah R, Wang X, Mehmood A, Wang Y. Gut microbiome as a treatment in colorectal cancer. Int Rev Immunol. 2024 Feb 12:1-19. DOI:10.1080/08830185.2024.2312294. Epub ahead of print. PMID: 38343353.

Ji M, Xu X, Xu Q, Hsiao YC, Martin C, Ukraintseva S, Popov V, Arbeev KG, Randall TA, Wu X, Garcia-Peterson LM, Liu J, Xu X, Andrea Azcarate-Peril M, Wan Y, Yashin AI, Anantharaman K, Lu K, Li JL, Shats I, Li X. Methionine restriction-induced sulfur deficiency impairs antitumour immunity partially through gut microbiota. Nat Metab. 2023 Sep;5(9): 1526-1543. DOI: 10.1038/s42255-023-00854-3. Epub 2023 Aug 3.

PMID: 37537369; PMCID: PMC10513933.

Zhao LY, Mei JX, Yu G, Lei L, Zhang WH, Liu K, Chen XL, Kołat D, Yang K, Hu JK. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. Signal Transduct Target Ther. 2023 May 13;8(1):201. DOI: 10.1038/s41392-023-01406-7.

PMID: 37179402; PMCID: PMC10183032.

Masenga SK, Hamooya B, Hangoma J, Hayumbu V, Ertuglu LA, Ishimwe J, Rahman S, Saleem M, Laffer CL, Elijovich F, Kirabo A. Recent advances in modulation of cardiovascular diseases by the gut microbiota. J Hum Hypertens. 2022 Nov;36(11):952-959. DOI: 10.1038/s41371-022-00698-6. Epub 2022 Apr 25.

PMID: 35469059; PMCID: PMC9649420.

Rein M, Ben-Yacov O, Godneva A. et al. Effects of personalized diets by predicting glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial. BMC Med. 2022;20:56.

Available: https://doi.org/10.1186/s12916-022-02254-y

Vandeputte D, Falony G, Vieira-Silva S, Tito RY, Joossens M, Raes J. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut. 2016 Jan;65(1):57-62. DOI: 10.1136/gutjnl-2015-309618. Epub 2015 Jun 11.

PMID: 26069274; PMCID: PMC4717365.

Qiu B, Shen Z, Yang D, Qin X, Ren W, Wang Q. Gut microbiota and common gastrointestinal diseases: a bidirectional two-sample Mendelian randomized study. Front Microbiol. 2023 Nov 17;14:1273269. doi: 10.3389/fmicb.2023.1273269. PMID: 38045030; PMCID: PMC10691374.

Aryal S, Alimadadi A, Manandhar I, Joe B, Cheng X. Machine Learning Strategy for Gut Microbiome-Based Diagnostic Screening of Cardiovascular Disease. Hypertension (Dallas, Tex. :1979). 2020 Nov;76(5):1555-1562. DOI: 10.1161/hypertensionaha.120.15885. PMID: 32909848; PMCID: PMC7577586.

Xue X, Li R, Chen Z, Li G, Liu B, Guo S, Yue Q, Yang S, Xie L, Zhang Y, Zhao J, Tan R. The role of the symbiotic micro-ecosystem in cancer: gut microbiota, metabolome, and host immunome. Front Immunol. 2023 Aug 24;14:1235827. DOI: 10.3389/fimmu.2023.1235827. PMID: 37691931; PMCID: PMC10484231

Rahman MM, Islam F, -Or-Rashid MH, Mamun AA, Rahaman MS, Islam MM, Meem AFK, Sutradhar PR, Mitra S, Mimi AA, Emran TB, Fatimawali, Idroes R, Tallei TE, Ahmed M, Cavalu S. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation. Front Cell Infect Microbiol. 2022 Jun 20;12:903570. DOI: 10.3389/fcimb.2022.903570. PMID: 35795187; PMCID: PMC9251340.

Shang L, Tu J, Dai Z, Zeng X, Qiao S. Microbiota Transplantation in an Antibiotic-Induced Bacterial Depletion Mouse Model: Reproducible Establishment, Analysis, and Application. Microorganisms. 2022 Apr 26;10(5):902. DOI: 10.3390/microorganisms10050902. PMID: 35630347; PMCID: PMC9146686.

Sun HJ, Wu ZY, Nie XW, Wang XY, Bian JS. An Updated Insight Into Molecular Mechanism of Hydrogen Sulfide in Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury Under Diabetes. Frontiers in Pharmacology. 2021;12:651884. DOI: 10.3389/fphar.2021.651884.

PMID: 34764865; PMCID: PMC8576408.

Kim ES, Yoon BH, Lee SM, Choi M, Kim EH, Lee BW, Kim SY, Pack CG, Sung YH, Baek IJ, Jung CH, Kim TB, Jeong JY, Ha CH. Fecal microbiota transplantation ameliorates atherosclerosis in mice with C1q/TNF-related protein 9 genetic deficiency. Exp Mol Med. 2022 Feb;54(2):103-114. DOI:10.1038/s12276-022-00728-w. Epub 2022 Feb 3.

PMID: 35115674; PMCID: PMC8894390.

Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nature reviews Gastroenterology & hepatology. 2012 Oct;9(10):599-608.

Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Reddy DN. Role of the normal gut microbiota. World journal of gastroenterology: WJG. 2015 Aug 8;21(29):8787.

Góralczyk-Bińkowska A, Szmajda-Krygier D, Kozłowska E. The Microbiota-Gut-Brain Axis in Psychiatric Disorders. Int J Mol Sci. 2022 Sep 24;23(19):11245. DOI: 10.3390/ijms231911245. PMID: 36232548; PMCID: PMC9570195.

Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019 Feb;76(3):473-493. doi: 10.1007/s00018-018-2943-4. Epub 2018 Oct 13. PMID: 30317530; PMCID: PMC11105460.

Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord. 2019 Dec;20(4):461-472. DOI: 10.1007/s11154-019-09512-0.

PMID: 31707624; PMCID: PMC6938793.

42. Ling Z, Liu X, Cheng Y, Yan X, Wu S. Gut microbiota and aging. Crit Rev Food Sci Nutr. 2022;62(13):3509-3534. DOI:10.1080/10408398.2020.1867054. Epub 2020 Dec 30. PMID: 33377391.

Qiu P, Ishimoto T, Fu L, Zhang J, Zhang Z, Liu Y. The Gut Microbiota in Inflammatory Bowel Disease. Front Cell Infect Microbiol. 2022 Feb 22;12:733992. DOI:10.3389/fcimb.2022.733992.

PMID: 35273921; PMCID: PMC8902753.

Asadi A, Shadab Mehr N, Mohamadi MH, Shokri F, Heidary M, Sadeghifard N, Khoshnood S. Obesity and gut-microbiota-brain axis: A narrative review. J Clin Lab Anal. 2022 May;36(5):e24420. DOI: 10.1002/jcla.24420. Epub 2022 Apr 14.

PMID: 35421277; PMCID: PMC9102524.

Wang J, Zhu N, Su X, Gao Y, Yang R. Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis. Cells. 2023 Mar 2;12(5):793. DOI: 10.3390/cells12050793. PMID: 36899929; PMCID: PMC10000530.

Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018 Feb;11(1):1-10. DOI: 10.1007/s12328-017-0813-5. Epub 2017 Dec 29. PMID: 29285689.

Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020 Jan 31;11:25. DOI: 10.3389/fendo.2020.00025.

PMID: 32082260; PMCID: PMC7005631.

Maynard C, Weinkove D. The Gut Microbiota and Ageing. Subcell Biochem. 2018;90:351-371. DOI: 10.1007/978-981-13-2835-0_12. PMID: 30779015.

Chen L, Wang J. Gut microbiota and inflammatory bowel disease. WIREs Mech Dis. 2022 Mar;14(2):e1540. DOI: 10.1002/wsbm.1540. Epub 2021 Oct 15. PMID: 35266651.

Illiano P, Brambilla R, Parolini C. The mutual interplay of gut microbiota, diet and human disease. FEBS J. 2020 Mar;287(5):833-855. DOI: 10.1111/febs.15217. Epub 2020 Feb 3. PMID: 31955527.

Ibrahim Ali Babekir R, Mergani A, Mohamed Elshiekh MY, Mohamed Nour BY. Prevalence of Some Diarrhea Pathogens among under 5, in Wad Medani Pediatric Teaching Hospital, Gezira State, Sudan. Int. J. Trop. Dis. Health. [Internet]. 2023 Feb. 13 [cited 2024 May 28];44(2):49-57. Available:https://journalijtdh.com/index.php/IJTDH/article/view/1389

Elmisbah HOII, Alonezy AAM, Alanazi STA, Alanazi SNA. Intestinal Obstruction Etiology, Diagnosis and Management. J. Pharm. Res. Int. [Internet]. 2022 Mar. 12 [cited 2024 May 28];34(23A):33-41. Available:https://journaljpri.com/index.php/JPRI/article/view/6103

Kim Y, Pritts TA. The gastrointestinal tract. Geriatric trauma and critical care. 2017:35-43. critical care. 2017:35-43.